companies developing glp-1 drugs Solving the Unmet Needs in Obesity Treatment | Obesity Pulse GLP-1 Receptor Agonist Market Size
Description
2010, doi: 10.1111/j.2040-1124.2010.00022.x
Supplementary information Supplementary Figures 113, Tables 110 and References Rights and permissions About this article Cite this article Boland, M.L., Laker, R.C., Mather, K
Stimulate insulin release 2
Estimated Sustainable Cost-based Prices for Diabetes Medicines
